Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON)

Medicina clínica
Laura AlonsoCristina Díaz de Heredia

Abstract

A recently occurring increase of the prevalence of haemoglobinopathies, β-thalassaemia major (TM) and sickle cell disease (SCD) over the last two decades in our country has generated new needs in terms of medical resources for both prevention and treatment of these patients. Allogeneic haematopoietic stem cell transplant (allo-HSCT) is a curative treatment available for patients who have severe haemoglobinopathies. The main objective of this study was to evaluate the results of allo-HSCT in paediatric patients with TM or SCD performed in paediatric hematopoietic transplant units within the Spanish Group of Bone Marrow Transplantation in Children (GETMON). Retrospective review of patients undergoing HSCT in the GETMON units until 2015. A total of 65 patients were analysed (43 patients were affected with TM and 22 with SCD), who received allo-HSCT in 6 GETMON units between November 1989 and December 2014. Event-free survival three years post-transplant was 81% and overall survival 92% in patients with TM. Event-free survival three years post-transplant was 79% and overall survival 85% in patients with SCD. The results of this series are comparable to the results of other international series and offer a platform from which to con...Continue Reading

Citations

Dec 10, 2020·European Journal of Haematology·María Isabel Benítez-CarabanteUNKNOWN Grupo Español de Trasplante de Médula Ósea en Niños (GETMON), Grupo Español de Trasplante Hematopoyético (GETH)
Nov 13, 2021·Medicine·Tang-Her JaingChia-Chi Chiu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Current Opinion in Hematology
Tara M Robinson, Ephraim J Fuchs
Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)
Marina García MorinCristina Beléndez
Pediatric Blood & Cancer
Elena CelaSEHOP-Hemoglobinopathies Study Group (Sociedad Española de Hematología y Oncología Pediátricas)
© 2022 Meta ULC. All rights reserved